Transdermal therapeutic system containing estradiol
US6521250B2 · kind B2 · utility
153Cited by
6References
24Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Mar 10, 2000 |
| Grant date | Feb 18, 2003 |
| Priority date | — |
| Expiry date | Mar 10, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P5/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An active-substance-containing transdermal therapeutic system for the controlled release of estradiol or its pharmaceutically acceptable able derivatives alone or combined with gestagens consisting of a layer, an active-substance-containing reservoir which is bonded thereto and produced by using pressure sensitive adhesives, and a removable protective layer is characterized by the fact that the pressure sensitive adhesive comprises esters of colophony.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.